Critical Survey: NeueHealth (NEUE) vs. Its Rivals

NeueHealth (NYSE:NEUE) is one of 14 public companies in the “Hospital & medical service plans” industry, but how does it contrast to its competitors? We will compare NeueHealth to related businesses based on the strength of its institutional ownership, earnings, dividends, risk, profitability, valuation and analyst recommendations.

Earnings and Valuation

This table compares NeueHealth and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NeueHealth	$1.16 billion	-$1.15 billion	-0.04
NeueHealth Competitors	$82.03 billion	$2.78 billion	8.81

NeueHealth’s competitors have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares NeueHealth and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeueHealth	-71.23%	N/A	-1.21%
NeueHealth Competitors	-0.07%	-2.39%	0.03%

Volatility & Risk

NeueHealth has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Comparatively, NeueHealth’s competitors have a beta of 0.95, meaning that their average stock price is 5% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings for NeueHealth and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0	1	0	0	2.00
NeueHealth Competitors	94	1125	2575	99	2.69

NeueHealth currently has a consensus price target of $8.00, indicating a potential upside of 24.61%. As a group, “Hospital & medical service plans” companies have a potential upside of 14.53%. Given NeueHealth’s higher probable upside, research analysts plainly believe NeueHealth is more favorable than its competitors.

Institutional and Insider Ownership

63.9% of NeueHealth shares are held by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are held by institutional investors. 64.3% of NeueHealth shares are held by insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

NeueHealth competitors beat NeueHealth on 10 of the 13 factors compared.

NeueHealth Company Profile

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.